Article | January 19, 2022

Patient Centricity Key To Clinical Trial Participation

By Informa Pharma Intelligence

iStock-1130696738-solution-child-patient-doctor-success

Over the past two years, the COVID-19 pandemic served as a focal point for the clinical trial landscape. However, many studies beyond the scope of coronavirus made major developments in the trial space, from Crohn’s disease to autoimmune diseases and Alzheimer’s. But in order to allow these trials to progress and provide the crucial data needed to make such strides, the industry needs to shift towards increasing patient-centric approaches to clinical trials.

Patient centricity allows the patient voice to be incorporated throughout the clinical trial process. Some initial steps in exploring this method include hosting focus groups, conducting live protocol simulations, working with patient advocacy organizations, and analyzing real-world data. By incorporating the patient perspective into each stage of the process, sponsors would increase enrollment as well as retention in clinical trials.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Informa Pharma Intelligence